Urovant Sciences® Announces Partnership with Thinx Inc. to Help

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., announced the launch of Time To GoTM today, a multi-channel educational camp

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

Huron Named Winner of the 2022 Workday Partner Innovation Awards in the Healthcare Industry

Stay Up to Date with Our News & Releases

University of Toronto Entrepreneurship U of T Entrepreneurship Week 2024: 10 startups to watch - University of Toronto Entrepreneurship

Myovant Sciences Stock News (MYOV)

Forward Looking NMIBC Treatment Advancements and Needs in 2024

Michelson Philanthropies and AAAS/Science Award Transformative Research

Next Science Partnerships - Next Science

Expanding CHB Treatment Criteria with Nucs as Prelude of Novel () ? - Harry Janssen, MD, PhD

Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC :: Tonix Pharmaceuticals Holding Corp. (TNXP)